申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP1748048A1
公开(公告)日:2007-01-31
The present invention provides an imidazopyridine compound represented by formula (I),
wherein R1 and R2 each independently represent a C1-6 alkyl group et al; R3 and R4 each independently represent a hydrogen atom, a methyl et al; Ar1 is a divalent substituent representing a monocyclic or bicyclic, 3- to 8-membered aromatic or aliphatic heterocyclic group et al; Ar2 represents an aromatic carbocyclic group, or an aromatic heterocyclic group; W represents -(CH2)m et al, and m indicates an integer of from 0 to 10. This compound acts as a melanin concentrating hormone receptor antagonist, and is useful as treating agents for obesity.
本发明提供了一种由式(I)代表的咪唑吡啶化合物、
其中 R1 和 R2 各自独立地代表 C1-6 烷基等;R3 和 R4 各自独立地代表氢原子、甲基等;Ar1 是二价取代基,代表单环或双环、3 至 8 元芳香族或脂肪族杂环基等;Ar2 代表芳香族碳环基团或芳香族杂环基团;W 代表-(CH2)m 等,m 表示 0 至 10 的整数。该化合物是一种黑色素浓缩激素受体拮抗剂,可作为肥胖症的治疗药物。